Detailed price information for Armata Pharmaceuticals Inc (ARMP-A) from The Globe and Mail including charting and trades.

FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...

Bacteria from cows has shown "promising" results in treating hospital superbugs. The farmyard favorites carry a microbe that ...

Antimicrobial resistance and ecological disruption caused by broad-spectrum disinfectants have created an urgent need for ...

The mucosal surfaces that line the body are embedded with defensive molecules that help keep microbes from causing ...

Picking your nose and then sticking those boogers to the wall may be convenient, but could come with unexpected health ...

Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published ...

Using robots and click chemistry, scientists built potential active ingredients for future antibiotics that contain metal.

Experts warn that antibiotic misuse is fueling drug-resistant infections like gonorrhoea and staph, making them harder to ...

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Researchers have developed a sunlight-activated nanospray that can rapidly kill drug-resistant bacteria, stop bleeding and relieve pain, significantly accelerating the healing of infected diabetic ...